Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2012
12/12/2012EP2531598A1 Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
12/12/2012EP2531597A2 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
12/12/2012EP2531527A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma
12/12/2012EP2531509A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/12/2012EP2531508A1 Pyrrolo [ 2, 3 - d]pyrimidine urea compounds as jak inhibitors
12/12/2012EP2531507A1 Crystalline forms of (s)-1-(4-(5-cyclopropyl-1h-pyrazol-3- ylamino)pyrrolo [1,2-f][1,2,4]triazin-2-yl)-n-(6-fluoropyridin- 3-yl)-2-methylpyrrolidine-2-carboxamide
12/12/2012EP2531502A1 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
12/12/2012EP2531498A1 Compounds and compositions as protein kinase inhibitors
12/12/2012EP2531488A2 Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors
12/12/2012EP2531213A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
12/12/2012EP2531211A1 Method for sensitizing cells to cancer therapy
12/12/2012EP2531207A2 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells
12/12/2012EP2531197A1 Solid state forms of macrocyclic kinase inhibitors
12/12/2012EP2531194A1 Identification of lkb1 mutation as a predictive biomarker for sensitivity to tor kinase inhibitors
12/12/2012EP2531193A1 Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same
12/12/2012EP2531032A1 Materials and method for inhibiting replication protein a and uses thereof
12/12/2012EP2531029A1 Selective androgen receptor modulators
12/12/2012CN1890567B Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/12/2012CN1678734B Differentiation modulating agents and uses thereof
12/12/2012CN102822676A Methods for predicting response of triple-negative breast cancer to therapy
12/12/2012CN102822335A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102822201A Anti-HER3 antibodies and uses thereof
12/12/2012CN102822200A Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
12/12/2012CN102822199A Medicinal composition for treating and/or preventing cancer
12/12/2012CN102822193A Modified MELK peptides and vaccines containing the same
12/12/2012CN102822190A Mammalian metabolites of steroids
12/12/2012CN102822177A Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors
12/12/2012CN102822173A Heterocyclic compounds and uses as anticancer agents
12/12/2012CN102822171A Benzonaphthyridinamines as autotaxin inhibitors
12/12/2012CN102822170A Substituted N-(1H-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cFMS inhibitors
12/12/2012CN102822169A Substituted naphthalenyl-pyrimidine compounds
12/12/2012CN102822165A Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/12/2012CN102822162A Compounds, compositions, formulations and their uses in the treatment diseases related to copper retention or hepatic disorders
12/12/2012CN102821789A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102821788A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102821778A Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of TIP41 which is a trail sensitizer target gene
12/12/2012CN102821777A Use of a neurofilament peptide for the treatment of glioma
12/12/2012CN102821769A Use of tigecycline for treatment of cancer
12/12/2012CN102821759A PKC inhibitors for the treatment of B-cell lymphoma having chronic active B-cell-receptor signalling
12/12/2012CN102816856A Application of DIAPH3 gene and expression product thereof
12/12/2012CN102816816A Bacillus sphaericus parasporal crystal protein preparation method and application thereof
12/12/2012CN102816793A Single carrier bidirectionally started Tet-on inducible expression system, its construction method and application
12/12/2012CN102816792A Method for regulating expression, quantity and activity of heat shock protein 70 and application thereof
12/12/2012CN102816743A Human ubiquitin ligase E3 for the modulation of NF-Kappa B
12/12/2012CN102816742A Chimeric adenoviruses for use in cancer treatment
12/12/2012CN102816239A Specific composite IgY (immunoglobulin of yolk) for resisting human telomerase reverse transcriptase (hTERT) and human epidermal growth factor receptor-2 (HER2) and preparation method of specific composite IgY
12/12/2012CN102816225A Metastatic tumor deletion protein inhibitor polypeptide
12/12/2012CN102816209A Chemokine-derived peptide, its expression gene and application thereof
12/12/2012CN102816198A Preparation method of 3-hydroxy-5-alkenesteroid compounds with ammonia derivative branched chain structure and application thereof in antineoplastic drugs
12/12/2012CN102816195A Gamma-lactone derivative as well as application and preparation method thereof
12/12/2012CN102816194A Macrocyclic compounds and methods of making and using the same
12/12/2012CN102816175A Heterocyclic and pyridone type compound, intermediate, preparation method and application thereof
12/12/2012CN102816162A Pyrimidine, pyrimidone compound, and medical compound and application thereof
12/12/2012CN102816159A Alpha-mangostin thiazole formate A, as well as semi-synthesis method and pharmaceutical application thereof
12/12/2012CN102816147A Flumatinib mesylate crystal form B and preparation method and use thereof
12/12/2012CN102816146A Flumatinib mesylate crystal form A and preparation method and use thereof
12/12/2012CN102816145A Methanesulfonic acid imatinib polymorphic substance and medical combination thereof
12/12/2012CN102816124A Hydroxylated and methoxylated cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
12/12/2012CN102816113A Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
12/12/2012CN102816079A New Co-crystals of Agomelatine, a Process for Their Preparation and Pharmaceutical Compositions Containing Them
12/12/2012CN102813940A Microrna as a cancer progression predictor and its use for treating cancer
12/12/2012CN102813939A Gene-viro-therapy medicine specific for prostate cancer
12/12/2012CN102813930A Preparation method of magnetically targeted localization magnetic drug carrier
12/12/2012CN102813916A Method for quickly preparing dentritic cell vaccine and application of dentritic cell vaccine
12/12/2012CN102813915A Drug-induced subcellular structure vaccine and preparation method thereof
12/12/2012CN102813913A Sichuan blackberry extract composition
12/12/2012CN102813878A Traditional Chinese medicine composition for treating recurrence of meningiomas after surgery
12/12/2012CN102813774A Traditional Chinese medicine combination for treating stony goiter and preparation method thereof
12/12/2012CN102813733A Herb tea capable of resisting cancer, preventing diabetes mellitus and enhancing immunity
12/12/2012CN102813685A Large specification glabrous scrcandra herb dripping pills and preparation method thereof
12/12/2012CN102813682A Stir-frying technology for Chinese yew powder rich in paclitaxel liposome by using membrane-ultrasonic wave dissolving technique
12/12/2012CN102813681A Preparation method of Cordyceps-toad skin composition
12/12/2012CN102813680A Pharmaceutical composition for auxiliary radiation therapy
12/12/2012CN102813672A Application of aluminum ammonium sulfate dodecahydrate in preparation of antitumor matrix metal protease inhibitors
12/12/2012CN102813669A Application of Isaria felina crude polysaccharide to preparation of anti-tumor drug
12/12/2012CN102813655A Formulations of a SRC/ABL inhibitor
12/12/2012CN102813647A New compound separated and identified from usnea longissima fruticose thallus
12/12/2012CN102813643A Application of bumetanide in inhibition of hepatoma cell transfer
12/12/2012CN102406946B High molecular adriamycin bonded medicament and preparation method thereof
12/12/2012CN102286435B Regulatory-cytokine-induced anti-apoptotic molecule (CIAPIN1) recombinant adenovirus and preparation method and use thereof
12/12/2012CN102283976B Drug for treating cancer
12/12/2012CN102242127B Preparation method of serial antibacterial peptide Alloferon-1 and application of rAlloferon-1-K
12/12/2012CN102229611B 2,6-diaryl pyrazolo[1,5-a]pyrazine-4(5H)-ketone compound and its application
12/12/2012CN102198096B ACA (acetoxychavicol acetate) submicron emulsion for intravenous injection, and preparation method and application thereof
12/12/2012CN102188467B Traditional Chinese medicine composition for reinforcing vital energy and consolidating constitution, boosting human immunity, resisting fatigue and tumor, and delaying aging
12/12/2012CN102154482B Application of calcium activated chloride channels ANO1/TMEM16A in diagnosis and treatment of prostate cancer
12/12/2012CN102153610B Nitric oxide donor type bile acid derivatives as well as preparation methods and medicinal application thereof
12/12/2012CN102138903B Everolimus solid oral medicinal composition
12/12/2012CN102127231B Glucan/polycaprolactone amphiphilic block polymer and preparation method and application thereof
12/12/2012CN102078569B Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof
12/12/2012CN102006866B Kinase protein binding inhibitors
12/12/2012CN101928234B 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same
12/12/2012CN101875648B Method for extracting and purifying Pinostrobin from medicinal plants, and pharmaceutical preparation and application thereof
12/12/2012CN101837129B Medicament composition containing cMet inhibitor, HDAC (Histone Deacetylases) inhibitor and EGFR (Epidermal Growth Factor Receptor) tyrosine kinase inhibitor and application thereof
12/12/2012CN101772507B Proteasome inhibitors
12/12/2012CN101757626B Pharmaceutical composition containing insulin-like growth factor-I receptor inhibitor and histon deacetylase (HDAC) inhibitor and application thereof
12/12/2012CN101679401B 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors
12/12/2012CN101665449B Water-soluble prodrug of tamibarotene, and preparation method and applications thereof
12/12/2012CN101659694B Anti-tumor cyclic pentapeptide compound and preparation method thereof
12/12/2012CN101633695B Preparation method of anti-erbB2 functional antibody based on erbB2 protein extracellular C-terminal functional epitope characteristics
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 2211